Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway

• Yashu Wang,

  Roles Writing – original draft

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Xinna Deng,

  Roles Methodology, Writing – original draft

  Affiliation Department of Oncology, Hebei General Hospital, Shijiazhuang, China

  ⨯
• Jinying Wei,

  Roles Data curation

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Zhaohua Yang,

  Roles Validation

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Yunxia Du,

  Roles Investigation

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Shan Song,

  Roles Supervision

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Yonghong Shi,

  Roles Supervision

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Haijiang Wu

  Roles Writing – review & editing

  * E-mail: haijianglaoqi@163.com

  Affiliation Department of Pathology, Hebei Medical University, Shijiazhuang, China

  https://orcid.org/0000-0003-1132-0352

  ⨯